Egis’s website uses cookies to run our website, improve the user experience and monitor the activities. You can customize the use of the cookies by adapting the settings.
Principles of Pharmacovigilance
Please report any adverse events
Main location
| Address | 121552, Moscow, Yartsevskaya str., 19, block B, floor 13 |
| Mail address | 121552, Moscow, Yartsevskaya str., 19, block B, floor 13 |
| Phone | +7 (495) 363-39-66 |
| moscow@egis.ru |
Write to us
Please report any adverse events possibly related to the products of Egis Pharmaceuticals PLC, at any of the following contacts:
E-mail: pharmacovigilance@egis.ru (please write your contact details for fast-ating feedback)
Telephone: +7 (495) 363-39-66 (24/7).
Corporate contacts
You can use the following online contact form to send a message to our department that is responsible for the selected topic.
For Mass Media, Authorities
gov@egis.ruHuman resourses
resume@egis.ruCompliance issues
сompliance@egis.ruQuality Assurance
claims@egis.ruProduction sites and offices
Egis Pharmaceuticals PLC
| Address: | 1106 Budapest, Keresztúri út 30-38, Hungary |
| Phone: | +36 1 803-5555 |
| Telefax: | +36 1 803-5529 |
Egis Pharmaceuticals PLC, Bökényföldi road
| Address: | 1165 Budapest, Lehel utca 118-120., Hungary |
| Phone: | +36 1 803-4222 |
| Telefax: | +36 1 803-4222 |
Egis Pharmaceuticals PLC Production Site of Körmend
| Address: | 9900 Körmend, Mátyás király utca 65., Hungary |
| Phone: | +36 94 883-100 |
| Telefax: | +36 94 410-622 |
About the company
Corporate information
Russian legal entity
Abbreviated
Egis Pharmaceuticals PLC
Postal address
Russia, 121552, Moscow, Yartsevskaya, 19, 13th floor, block B
Headquarters
H-1106 Budapest, Keresztúri út 30-38.
Principles of Pharmacovigilance
Please report any adverse events
Principles of Pharmacovigilance
Egis Pharmaceuticals PLC is committed to the safe use of drugs. Therefore we pay special attention to the collection and evaluation of the adverse events and quality complaints experienced in relation to the use of our products.
Our aim is to provide patients, physicians and pharmacists who use our products with information, which reflects the current views of medical science and which contains all the data and knowledge necessary for the safe use of our products in order to facilitate the patients’ recovery and to minimize the risks of side effects.
To reach this goal we need the cooperation of patients, practicing physicians and pharmacists in reporting suspected adverse drug reactions noticed in their professional practice. It is our firm belief that the safety of medicinal treatment is our common interest.
Please report any adverse events possibly related to the products of Egis Pharmaceuticals PLC, at any of the following contacts:
E-mail: pharmacovigilance@egis.ru
Telephone: +7 (495) 363-39-66
Your browser is out of date. Please, use an updated version!